BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18039381)

  • 1. Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?
    Carroll RJ; Mulla ZD; Hauck LD; Westbrook A
    BMC Cardiovasc Disord; 2007 Nov; 7():37. PubMed ID: 18039381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nesiritide in acute heart failure.
    Knox MA; Dancy T; Mook W; Pschirer JJ
    Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
    Gerhard T; Zineh I; Winterstein AG; Hartzema AG
    Pharmacotherapy; 2006 Jan; 26(1):34-43. PubMed ID: 16509026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with nesiritide administration for acute decompensated heart failure in the emergency department observation unit: a single center experience.
    Styron JF; Jois-Bilowich P; Tallman T; Emerman C; Starling RC; Frank Peacock W
    Congest Heart Fail; 2009; 15(3):103-7. PubMed ID: 19522957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
    N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.
    Strain WD
    Int J Clin Pract; 2004 Nov; 58(11):1081-7. PubMed ID: 15605677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF.
    Patel PA; Heizer G; O'Connor CM; Schulte PJ; Dickstein K; Ezekowitz JA; Armstrong PW; Hasselblad V; Mills RM; McMurray JJ; Starling RC; Tang WH; Califf RM; Hernandez AF
    Circ Heart Fail; 2014 Nov; 7(6):918-25. PubMed ID: 25281655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
    Abraham WT; Cheng ML; Smoluk G;
    Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesiritide Therapy Is Associated With Better Clinical Outcomes Than Dobutamine Therapy in Heart Failure.
    Kong LG; Wang CL; Zhao D; Wang B
    Am J Ther; 2017; 24(2):e181-e188. PubMed ID: 26164026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.
    Abraham WT; Trupp RJ; Jarjoura D
    Clin Cardiol; 2010 Aug; 33(8):484-9. PubMed ID: 20734445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure.
    de Lissovoy G; Stier DM; Ciesla G; Munger M; Burger AJ
    Am J Cardiol; 2003 Sep; 92(5):631-3. PubMed ID: 12943895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.